Merck suffers a setback over its new Keytruda formulation in Germany The Munich Regional Court decided that Merck’s formulation would infringe on a patent held by Halozyme Therapeutics

https://www.statnews.com/pharmalot/2025/12/04/merck-keytruda-patent-halozyme-germany-europe-united-states/